Company Profile
Updated: 17-SEP-09Rosetta Inpharmatics L.L.C.
Private Subsidiary, Headquarters Location
401 Terry Ave. N, Seattle, WA 98104, United States
(206)802-7000, (206)926-1299 fax, http://www.rii.com
Primary SIC: Prepackaged Software, Primary NAICS: Software Publishers
Description: Services: Developer of software for use in genomics. Manufacturing: Bioinformatics equipment and software and other laboratory analytical equipment.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
The Critical Path Institute Adopts the Rosetta Resolver(R) System for the Predictive Safety Testing Consortium.
Business Wire; 3/19/2007; 1301 words; ...amp; TUCSON, Ariz. -- Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver[R] system for C-Path's Predictive Safety...AstraZeneca Pharmaceuticals, L.P., Boehringer-Ingelheim...
Toxicogenomics and Related Approaches: The Promise of Safer, Smarter Drug Development.
M2 Presswire; 12/17/2002; 1443 words; ...Safer, Smarter Drug Development(C)1994-2002 M2 COMMUNICATIONS LTD...Doug Dolginow, Gene Logic; David L. Eaton, University of Washington...Bioscience Abbott Laboratories and Rosetta Inpharmatics University of California, Davis...
Who's Who in Healthcare Finance - Cont'd.
Investment Dealers' Digest; 4/15/2002; 6265 words; ...620 million acquisition of Rosetta Inpharmatics and Sole Bookrunner on...Head (New York) Kristin L. Carey, Managing Director...Director (New York) Robert L. Huffines, Managing Director...Analyst (London) Roopesh C. Patel, Vice President...
Who's Who in Healthcare Finance cont'd.(Directory)
Investment Dealers' Digest; 10/22/2001; 2339 words; ...New York) Kristin L. Carey, Managing...London) Roopesh C. Patel, Vice President...New York) Lisa C. Gill, Vice President...San Francisco) Ken L. Miller, M.D...Pharmaceuticals division Rosetta Inpharmatics, Inc. - Sale of...
The Seattle Times Business Newsletter Column.
Knight Ridder/Tribune Business News; 10/10/2001; 926 words; ...gave his stock in Rosetta Inpharmatics, a biotech company...this newspaper. Rosetta was sold to Merck...1 million when Rosetta was acquired. If...Another S&L was cited because...seattletimes.com. (c) 2001, The Seattle...
Recent News Articles
- Researchers at Rosetta Inpharmatics, LLC have published new data on life sciences.
Biotech Week - December 31, 2008 - Stratagene entered into a joint development and license agreement with Rosetta Inpharmatics, a unit of Merck & Co., to create an automated solution for the isolation of nucleic acids from a variety of clinical samples.(Nucleic Acid Amplification: Company Announcements)
Instrument Business Outlook - October 15, 2006 - Stratagene and Merck Subsidiary, Rosetta Inpharmatics, Enter into Joint Development and License Agreement; Companies Will Develop RNA Purification System for Use in Molecular Diagnostics and Research Applications.
Business Wire - August 14, 2006 - Sigma-Aldrich exclusively licensed Rosetta Inpharmatics.(Life Science Consumables: Company Announcements)
Instrument Business Outlook - July 31, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning